Clinical Trials Logo

Clinical Trial Summary

The purpose of this study was to determine the safety of AZX100 Drug Product and to determine whether it was effective in preventing or reducing scars that were made from trocars following arthroscopic shoulder surgery.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Prevention


Related Conditions & MeSH terms


NCT number NCT00811577
Study type Interventional
Source Capstone Therapeutics
Contact
Status Completed
Phase Phase 2
Start date January 2009
Completion date December 2010

See also
  Status Clinical Trial Phase
Completed NCT00892723 - A Study to Evaluate the Safety and Efficacy of Additional Doses of AZX100 Drug Product Following Excision of Keloid Scars Phase 2
Active, not recruiting NCT06312527 - Mepiform in Simultaneous Bilateral TKA N/A
Completed NCT00825916 - A Study to Evaluate the Safety and Efficacy of AZX100 Drug Product Following Excision of Keloid Scars Phase 2
Completed NCT01640912 - Evaluation of the Safety, Pharmacokinetics, and Preliminary Effect on Scar Formation by RXI-109 Phase 1
Completed NCT04707131 - A Study of Single Ascending Dose of LEM-S401 in Healthy Participants Phase 1
Recruiting NCT04722705 - Combined Intense Pulsed Light (IPL) With Fractional Erbium:YAG Laser Ablation in Scar Prevention N/A
Terminated NCT01826942 - Scar Prevention Using Fractional Carbon Dioxide Laser Treatment N/A
Completed NCT01037985 - Safety and Efficacy Study of EXC 001 to Improve the Appearance of Scars in Subjects Undergoing Elective Abdominoplasty Phase 2
Completed NCT01037413 - Safety and Efficacy Study of EXC 001 to Improve the Appearance of Scars From Prior Breast Surgery Phase 2
Completed NCT01780077 - Evaluation of Safety, PK, and Preliminary Effects on Scar Formation of Multiple Intradermal Administrations of RXI-109 Phase 1
Completed NCT01038297 - Safety and Efficacy Study of Different Dose Levels of EXC 001 to Improve the Appearance of Scars in Subjects Undergoing Elective Abdominoplasty Phase 2